Todd Bazemore is COO at Kala Pharmaceuticals, Inc. (KALA). They have made 4 open-market trades across 2 companies since 2015, most recently 2025-10-22.
CIK 0001605767
2 open-market purchases totalling $58K since 2020, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALA | SELL | 2025-10-22 | 2025-10-24 | $0.83 | $40K | -3.9% | -22.2% | -25.6% |
| KALA | SELL · 10b5-1 | 2025-06-24 | 2025-06-26 | $4.01 | $16K | +16.5% | +46.6% | +253.7% |
| KALA | SELL · 10b5-1 | 2025-06-03 | 2025-06-04 | $3.74 | $13K | +7.2% | +30.4% | +201.0% |
| KALA | SELL · 10b5-1 | 2025-01-06 | 2025-01-07 | $7.63 | $15K | +2.5% | +43.3% | -50.1% |
| KALA | SELL · 10b5-1 | 2024-06-26 | 2024-06-27 | $4.75 | $22K | +13.1% | +5.2% | -18.8% |
| KALA | SELL · 10b5-1 | 2024-05-31 | 2024-06-03 | $6.09 | $13K | -11.9% | +0.1% | -13.5% |
| KALA | SELL · 10b5-1 | 2024-01-04 | 2024-01-05 | $6.74 | $9K | +20.4% | -0.4% | +10.8% |
| KALA | SELL · 10b5-1 | 2023-01-04 | 2023-01-06 | $28.54 | $2K | -35.8% | -41.0% | -50.1% |
| KALA | SELL · 10b5-1 | 2022-10-26 | 2022-10-28 | $6.51 | $1K | +6.5% | -6.5% | +215.1% |
| KALA | SELL · 10b5-1 | 2022-06-27 | 2022-06-29 | $0.37 | $1K | +8.1% | +6.5% | -24.5% |
| KALA | SELL · 10b5-1 | 2022-01-04 | 2022-01-05 | $1.30 | $4K | -19.1% | -32.1% | +5.2% |
| KALA | SELL · 10b5-1 | 2021-10-26 | 2021-10-28 | $1.80 | $23K | +23.6% | +6.3% | -51.0% |
| KALA | SELL · 10b5-1 | 2021-06-28 | 2021-06-29 | $5.77 | $17K | -16.9% | -35.1% | -44.9% |
| KALA | BUY | 2020-06-05 | 2020-10-28 | $7.88 | $331 | +5.4% | +6.1% | +4.7% |
| KALA | BUY | 2020-03-16 | 2020-03-17 | $5.75 | $58K | +8.2% | +36.5% | +90.0% |
| DYAX | SELL | 2015-08-04 | 2015-08-06 | $23.62 | $1.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.